Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Rat Bone Healing Response to Novel Anabolic Treatment
FY 2022-23
Summary
Bone healing is a tightly regulated process involving a cascade of events, to which various cells and molecular factors contribute. Worldwide, up to 5% of fractures exhibit non-union of the fracture gap (Wildemann, 2021), especially when the gap is critical sized. Further, the effectiveness of current pharmacological therapies for bone healing can wane after short periods of use and display other complications (Schmidt-Bleek, 2016). The primary goal of this project is to address the need for competent bone healing treatment by evaluating the effect of Mes-1022, an anabolic bone-targeting drug, on critical size femoral bone defect healing in rats when administered systemically. We divided 60 rats into 3 cohorts and injected them weekly over 12 weeks with either (1) 1.7 mg/kg Mes-1022, (2) 5 mg/kg Mes-1022, or (3) vehicle. On the first day of drug injection, rats undergo an osteotomy to create a critical size defect, stabilized by an external fixator. To assess the effects of the drug, rats are subjected to activity analysis and blood collection to monitor bone markers. At study endpoint, rats are euthanized and the femurs, along with other bones, soft tissues, and organs are dissected. Osteotomized femurs are scanned using microcomputed tomography at the defect site to quantify bone volume fraction and to characterize osteocyte lacunae. Then, they are embedded and sectioned for histological analysis. Contralateral femurs are scanned to assess bone microstructure, then are subject to 3 point bending testing to determine bone strength. Organs are weighed and analyzed histologically. The results of this study will further the understanding of the effects of Mes-1022 on bone structure, quality, and healing, and also expedite its potential to advance into clinical research.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486542
Name
Chapman Jack
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Rat Bone Healing Response to Novel Anabolic Treatment
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood Bone Markers; Bone; Bone Fracture Healing; Bone Mechanobiology; Bone Remodeling; Histology; Microct; Osteoporosis; Preclinical Research; Systemic Drug Treatment
Abstract
Bone healing is a tightly regulated process involving a cascade of events, to which various cells and molecular factors contribute. Worldwide, up to 5% of fractures exhibit non-union of the fracture gap (Wildemann, 2021), especially when the gap is critical sized. Further, the effectiveness of current pharmacological therapies for bone healing can wane after short periods of use and display other complications (Schmidt-Bleek, 2016). The primary goal of this project is to address the need for competent bone healing treatment by evaluating the effect of Mes-1022, an anabolic bone-targeting drug, on critical size femoral bone defect healing in rats when administered systemically. We divided 60 rats into 3 cohorts and injected them weekly over 12 weeks with either (1) 1.7 mg/kg Mes-1022, (2) 5 mg/kg Mes-1022, or (3) vehicle. On the first day of drug injection, rats undergo an osteotomy to create a critical size defect, stabilized by an external fixator. To assess the effects of the drug, rats are subjected to activity analysis and blood collection to monitor bone markers. At study endpoint, rats are euthanized and the femurs, along with other bones, soft tissues, and organs are dissected. Osteotomized femurs are scanned using microcomputed tomography at the defect site to quantify bone volume fraction and to characterize osteocyte lacunae. Then, they are embedded and sectioned for histological analysis. Contralateral femurs are scanned to assess bone microstructure, then are subject to 3 point bending testing to determine bone strength. Organs are weighed and analyzed histologically. The results of this study will further the understanding of the effects of Mes-1022 on bone structure, quality, and healing, and also expedite its potential to advance into clinical research.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chapman, Jack
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~